当前位置:
X-MOL 学术
›
J. Rheumatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Clinical Heterogeneity of Patients With Antinuclear Matrix Protein 2 Antibody-Positive Myositis: A Retrospective Cohort Study in China.
The Journal of Rheumatology ( IF 3.9 ) Pub Date : 2022-06-15 , DOI: 10.3899/jrheum.211234 Shanshan Li 1 , Chao Sun 1 , Ling Zhang 2 , Junfeng Han 3 , Hanbo Yang 1 , Suhao Gao 4 , Linrong He 1 , Peiyao Zhang 2 , Xin Lu 1 , Xiaoming Shu 5 , Guochun Wang 1
The Journal of Rheumatology ( IF 3.9 ) Pub Date : 2022-06-15 , DOI: 10.3899/jrheum.211234 Shanshan Li 1 , Chao Sun 1 , Ling Zhang 2 , Junfeng Han 3 , Hanbo Yang 1 , Suhao Gao 4 , Linrong He 1 , Peiyao Zhang 2 , Xin Lu 1 , Xiaoming Shu 5 , Guochun Wang 1
Affiliation
Heterogeneity exists among patients with myositis who have antinuclear matrix protein 2 (anti-NXP2) antibodies, although they usually present with severe muscle weakness. This study aimed to investigate the differences in phenotypes and prognoses among adult patients with myositis who have anti-NXP2 antibodies.
更新日期:2022-06-15